Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Sladden

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|February 16, 2018
Adjuvant Therapy in Resected MelanomaMichael Sladden, Samuel Zagarella, Michael Bigby
Journal of the American Academy of Dermatology|April 1, 2019
Letter to the editorSamuel Zagarella, Michael Bigby, Michael Sladden, et al.
The Australasian Journal of Dermatology|November 10, 2021
Dual biologic therapy with Omalizumab and Dupilumab for refractory atopic diseaseAlexis Arasu, Niyati Sharma, Anousha Yazdabadi, et al.
The Australasian Journal of Dermatology|February 8, 2018
When is a sentinel node biopsy indicated for patients with primary melanoma? Comment on the 'Australian guidelines for the management of cutaneous melanoma'Michael Sladden, Samuel Zagarella, Catalin Popescu, et al.
The Medical Journal of Australia|January 29, 2015
Sentinel lymph node biopsy for melanoma: an important risk-stratification toolSamuel S Zagarella, Michael Sladden, Catalin Popescu, et al.
Journal of the American Academy of Dermatology|November 25, 2018
Time to reconsider the role of sentinel lymph node biopsy in melanomaMichael Bigby, Samuel Zagarella, Michael Sladden, et al.
Australian Family Physician|August 11, 2016
Sentinel node biopsy should not be the standard of care for patients with intermediate and thick melanomasSamuel Zagarella, Michael Sladden, Catalin Popescu, et al.
Experimental Dermatology|January 7, 2026
Paediatric-Onset Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum: Is It a Different Disease?Andrew Awad, Yong Chern Kho, Leila Asfour, et al.
Implementation Science : IS|September 26, 2007
Educational outreach to general practitioners reduces children's asthma symptoms: a cluster randomised controlled trialMerrick Zwarenstein, Angeni Bheekie, Carl Lombard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 31, 2024
BAUSSS biomarker improves melanoma survival risk assessmentAnthony J Dixon, Howard K Steinman, Alexander Nirenberg, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|February 16, 2018
Adjuvant Therapy in Resected MelanomaMichael Sladden, Samuel Zagarella, Michael Bigby
Journal of the American Academy of Dermatology|April 1, 2019
Letter to the editorSamuel Zagarella, Michael Bigby, Michael Sladden, et al.
The Australasian Journal of Dermatology|November 10, 2021
Dual biologic therapy with Omalizumab and Dupilumab for refractory atopic diseaseAlexis Arasu, Niyati Sharma, Anousha Yazdabadi, et al.
The Australasian Journal of Dermatology|February 8, 2018
When is a sentinel node biopsy indicated for patients with primary melanoma? Comment on the 'Australian guidelines for the management of cutaneous melanoma'Michael Sladden, Samuel Zagarella, Catalin Popescu, et al.
The Medical Journal of Australia|January 29, 2015
Sentinel lymph node biopsy for melanoma: an important risk-stratification toolSamuel S Zagarella, Michael Sladden, Catalin Popescu, et al.
Journal of the American Academy of Dermatology|November 25, 2018
Time to reconsider the role of sentinel lymph node biopsy in melanomaMichael Bigby, Samuel Zagarella, Michael Sladden, et al.
Australian Family Physician|August 11, 2016
Sentinel node biopsy should not be the standard of care for patients with intermediate and thick melanomasSamuel Zagarella, Michael Sladden, Catalin Popescu, et al.
Experimental Dermatology|January 7, 2026
Paediatric-Onset Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum: Is It a Different Disease?Andrew Awad, Yong Chern Kho, Leila Asfour, et al.
Implementation Science : IS|September 26, 2007
Educational outreach to general practitioners reduces children's asthma symptoms: a cluster randomised controlled trialMerrick Zwarenstein, Angeni Bheekie, Carl Lombard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 31, 2024
BAUSSS biomarker improves melanoma survival risk assessmentAnthony J Dixon, Howard K Steinman, Alexander Nirenberg, et al.
Pageof 2